about plasma

woman testing

About Plasma

Due to the theoretical risk of vCJD transmission posed by UK plasma, BPL sources all its plasma from plasma collection centres in the US, primarily from Life Resources Incorporated, which is wholly owned by the UK Department of Health.

Our products are manufactured using US plasma collected by internationally respected and highly regulated blood or plasma collection establishments.  Although we are a UK organisation, we only use plasma from the US.

Only a limited number of donor centres are used, and all of these are licensed by the FDA. All establishments are audited by UK or other EU authorities.

All potential donors have their identities confirmed, and have to pass interviews on lifestyle and health history.

In 1991, the Plasma Protein Therapeutics Association (PPTA) introduced the Quality Plasma Program - QPP. It was designed to maintain quality, safety and consistency in the collection and supply of plasma across the US.  In 2000, the QPP program was made available to plasma centres outside of the US and was renamed the International Quality Plasma Program (IQPP). PPTA Source developed the Qualified Donor Standard, which led to a more comprehensive Viral Marker Standard. IQPP is based on the following criteria:

  • Donor screening exceeding FDA requirements.


  • Maintenance and monitoring of stringent quality standards in the collection process.


  • Maintenance of the National Donor Deferral Registry (NDDR) which records all deferred donations for whatever reason, and allows for the verification of donor suitability prior to donation.


  • Encouragement of donor education and self-exclusion.


  • Thorough employee education and training. All sourced plasma utilised by BPL is collected under IQPP.

For further information, please visit the PPTA website: http://www.pptaglobal.org/

Patient information leaflets